Duloxetine
Product Images NDC 68788-6380

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 68788-6380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Duloxetine 01)

Chemical structure of duloxetine hydrochloride showing its molecular arrangement, including a thiophene ring, a naphthyl group, and an amine hydrochloride component.*

FDA Label Image

Figure 1 (Duloxetine 02)

A line chart comparing the proportion of patients with relapse over time between Duloxetine and placebo treatment groups. The x-axis represents time from randomization to relapse in days (0 to 250), and the y-axis shows the proportion of patients with relapse (0.0 to 1.0). Duloxetine is shown with a solid line lower than the placebo dashed line, indicating fewer relapses over time.*

FDA Label Image

Figure 2 (Duloxetine 03)

A line graph showing the proportion of patients with relapse over time in days from randomization. Two treatment groups are compared: Placebo (dashed line) and Duloxetine (solid line), illustrating that the Duloxetine group has a lower proportion of relapse over time compared to Placebo.*

FDA Label Image

Figure 3 (Duloxetine 04)

A line graph illustrating the percentage of patients improved relative to percent improvement in pain from baseline. It compares four groups: DULOXETINE DELAYED-RELEASE 60 mg twice daily (BID), 60 mg once daily (QD), 20 mg once daily (QD), and placebo. The graph shows the relationship between pain improvement and patient response rates for these dosages.*

FDA Label Image

Figure 4 (Duloxetine 05)

A line graph showing the percentage of patients improved versus percent improvement in pain from baseline for DULOXETINE DELAYED-RELEASE at two dosages (60 mg BID and 60 mg QD) compared to placebo. The graph includes a legend for the three groups and depicts patient response curves over increasing pain improvement percentages.*

FDA Label Image

Figure 7 (Duloxetine 06)

A line graph comparing the percentage of patients improved against the percent improvement in pain from baseline (BOCF) for Duloxetine Delayed-Release 60/120 mg once daily versus placebo. The x-axis represents percent improvement in pain, from greater than 0 to 100%, and the y-axis shows the percentage of patients improved, from 0 to 100%. Duloxetine generally shows a higher percentage of improvement across the range compared to placebo.*

FDA Label Image

Figure 8 (Duloxetine 07)

A line graph comparing the percentage of patients improved versus percent improvement in pain from baseline (BOCF). The graph includes two lines: one for placebo and one for DULOXETINE DELAYED-RELEASE 60 mg once daily. The y-axis shows the percentage of patients improved, and the x-axis shows the percent improvement in pain from baseline.*

FDA Label Image

Figure 9 (Duloxetine 08)

A line graph comparing the percentage of patients improved by placebo versus DUL 60/120 mg once daily, plotting percentage improvement in pain from baseline on the horizontal axis against percentage of patients improved on the vertical axis. DUL shows a higher patient improvement rate across increasing pain improvement thresholds.*

FDA Label Image

Duloxetine Delayed-release Capsules, Usp 20mg (Duloxetine 09)

Duloxetine Delayed-Release Capsule USP 20mg label for a generic of Cymbalta. The label shows each capsule contains 22.5mg of Duloxetine Hydrochloride equivalent to 20mg Duloxetine. Manufactured by Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. The label includes dosage instructions in English and Spanish on a yellow background, highlighting to take one capsule every specified hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.